User profiles for Kohei Kume

Kohei Kume

Yale University
Verified email at yale.edu
Cited by 647

[HTML][HTML] IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells

…, J Winchester, KN Cosgun, H Geng, LN Chan, K Kume… - Nature, 2020 - nature.com
Interferon-induced transmembrane protein 3 (IFITM3) has previously been identified as an
endosomal protein that blocks viral infection 1 , 2 – 3 . Here we studied clinical cohorts of …

Signalling input from divergent pathways subverts B cell transformation

…, R Caeser, T Sadras, J Lee, KN Cosgun, K Kume… - Nature, 2020 - nature.com
Malignant transformation of cells typically involves several genetic lesions, whose combined
activity gives rise to cancer 1 . Here we analyse 1,148 patient-derived B-cell leukaemia (B-…

[PDF][PDF] Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer

T Sadras, M Martin, K Kume, ME Robinson… - Molecular cell, 2021 - cell.com
Even though SYK and ZAP70 kinases share high sequence homology and serve analogous
functions, their expression in B and T cells is strictly segregated throughout evolution. Here, …

[HTML][HTML] Individualized mutation detection in circulating tumor DNA for monitoring colorectal tumor burden using a cancer-associated gene sequencing panel

KA Sato, T Hachiya, T Iwaya, K Kume, T Matsuo… - PloS one, 2016 - journals.plos.org
Background Circulating tumor DNA (ctDNA) carries information on tumor burden. However,
the mutation spectrum is different among tumors. This study was designed to examine the …

SYK and ZAP70 kinases in autoimmunity and lymphoid malignancies

E Leveille, LN Chan, AS Mirza, K Kume, M Müschen - Cellular signalling, 2022 - Elsevier
SYK and ZAP70 nonreceptor tyrosine kinases serve essential roles in initiating B-cell receptor
(BCR) and T-cell receptor (TCR) signaling in B- and T-lymphocytes, respectively. Despite …

Contrasting expression patterns of histone mRNA and microRNA 760 in patients with gastric cancer

…, K Shibata, F Endo, H Katagiri, K Ishida, K Kume… - Clinical Cancer …, 2013 - AACR
Purpose: Recent studies revealed that both disseminated tumor cells and noncancerous
cells contributed to cancer progression cooperatively in the bone marrow. Here, RNA-seq …

[HTML][HTML] α-Amanitin Restrains Cancer Relapse from Drug-Tolerant Cell Subpopulations via TAF15

K Kume, M Ikeda, S Miura, K Ito, KA Sato, Y Ohmori… - Scientific reports, 2016 - nature.com
Cancer relapse occurs with substantial frequency even after treatment with curative intent.
Here we studied drug-tolerant colonies (DTCs), which are subpopulations of cancer cells that …

PON2 subverts metabolic gatekeeper functions in B cells to promote leukemogenesis

…, KN Cosgun, L Xu, K Kume… - Proceedings of the …, 2021 - National Acad Sciences
Unlike other cell types, developing B cells undergo multiple rounds of somatic recombination
and hypermutation to evolve high-affinity antibodies. Reflecting the high frequency of DNA …

[HTML][HTML] A Compensatory role of NF-κB to p53 in response to 5-FU–based chemotherapy for gastric cancer cell lines

F Endo, SS Nishizuka, K Kume, K Ishida, H Katagiri… - PloS one, 2014 - journals.plos.org
Despite of remarkable improvement of postoperative 5-FU–based adjuvant chemotherapy,
the relapse rate of gastric cancer patients who undergo curative resection followed by the …

TAS1 trans-Acting siRNA Targets Are Differentially Regulated at Low Temperature, and TAS1 trans-Acting siRNA Mediates Temperature-Controlled At1g51670 …

K Kume, K Tsutsumi, Y Saitoh - Bioscience, biotechnology, and …, 2010 - academic.oup.com
To endure considerable fluctuations in temperature, plants need precise regulation of
temperature-controlled gene expression. In this study, the involvement of TAS1 trans-acting siRNA …